Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Mark A Buthman. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Mark A Buthman har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:IEX / IDEX Corporation Director 9.220
US:WST / West Pharmaceutical Services, Inc. Director 42.861
US:KMB / Kimberly-Clark Corporation Executive Vice President 99.355
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Mark A Buthman. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Mark A Buthman som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-05-12 2025-05-08 4 IEX IDEX CORP /DE/
COMMON STOCK
A - Award 895 9.220 10,75
2025-05-08 2025-05-06 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
A - Award 1.071 42.861 2,56
2024-05-08 2024-05-07 4 IEX IDEX CORP /DE/
COMMON STOCK
A - Award 745 8.325 9,83
2024-04-25 2024-04-23 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
A - Award 564 41.786 1,37
2023-05-30 2023-05-25 4 IEX IDEX CORP /DE/
COMMON STOCK
A - Award 770 7.580 11,31
2023-04-27 2023-04-25 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
A - Award 616 41.222 1,52
2022-05-26 2022-05-24 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
A - Award 632 40.606 1,58
2022-05-10 2022-05-06 4 IEX IDEX CORP /DE/
COMMON STOCK
A - Award 825 6.810 13,78
2022-01-04 2021-12-31 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 48 10.879 0,44 469,01 22.512 5.102.500
2021-10-01 2021-09-30 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 53 10.831 0,49 424,54 22.501 4.598.320
2021-07-01 2021-06-30 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 63 10.778 0,59 359,10 22.623 3.870.487
2021-05-14 2021-05-12 4 IEX IDEX CORP /DE/
COMMON STOCK
A - Award 665 5.985 12,50
2021-05-06 2021-05-04 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
A - Award 577 39.974 1,46
2021-04-13 2021-03-31 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 80 10.715 0,75 281,78 22.542 3.019.357
2020-05-11 2020-05-07 4 IEX IDEX CORP /DE/
COMMON STOCK
A - Award 950 5.320 21,74
2020-05-07 2020-05-05 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
A - Award 975 39.228 2,55
2020-01-09 2019-12-31 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 150 10.635 1,43 150,33 22.550 1.598.805
2019-10-02 2019-09-30 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 159 10.485 1,54 141,82 22.549 1.487.025
2019-07-02 2019-06-28 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 180 10.326 1,77 125,15 22.527 1.292.336
2019-05-14 2019-05-10 4 IEX IDEX CORP /DE/
COMMON STOCK
A - Award 845 4.370 23,97
2019-05-09 2019-05-07 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
A - Award 1.565 27.277 6,09
2019-04-02 2019-03-29 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 204 10.146 2,05 110,20 22.481 1.118.122
2019-01-03 2018-12-31 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 255 9.942 2,63 98,03 24.998 974.644
2018-10-02 2018-09-28 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 203 9.687 2,14 123,74 25.119 1.198.706
2018-08-01 2018-06-29 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 267 9.484 2,90 99,29 26.499 941.696
2018-08-01 2018-03-29 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 295 9.217 3,31 86,72 25.622 799.334
2018-08-01 2017-12-29 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 264 8.922 3,05 99,16 26.186 884.701
2018-05-03 2018-05-01 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
A - Award 1.824 25.607 7,67
2018-04-26 2018-04-25 4 IEX IDEX CORP /DE/
COMMON STOCK
A - Award 945 3.525 36,63
2017-10-03 2017-09-29 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 260 8.658 3,09 96,33 25.000 834.013
2017-07-05 2017-06-30 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 265 8.386 3,26 94,39 25.000 791.539
2017-05-03 2017-05-02 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
A - Award 1.697 23.717 7,71
2017-04-04 2017-03-31 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 306 8.110 3,92 81,69 25.000 662.487
2017-02-24 2017-02-22 4 IEX IDEX CORP /DE/
COMMON STOCK
A - Award 1.290 2.580 100,00
2017-01-04 2016-12-30 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 293 7.792 3,91 85,20 25.000 663.858
2016-10-04 2016-09-30 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 337 7.475 4,73 74,12 25.000 554.026
2016-07-05 2016-06-30 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 333 7.137 4,89 75,06 25.000 535.735
2016-05-05 2016-05-03 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
A - Award 2.262 21.882 11,53
2016-04-08 2016-04-06 4 IEX IDEX CORP /DE/
COMMON STOCK
A - Award 1.290 1.290
2016-04-04 2016-03-31 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 363 6.793 5,64 68,91 25.000 468.086
2016-01-08 2015-12-31 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 348 6.416 5,73 61,07 21.250 391.845
2015-11-19 2015-11-19 4 KMB KIMBERLY CLARK CORP
Common Stock
S - Sale -5.988 99.355 -5,68 122,00 -730.536 12.121.310
2015-10-05 2015-10-01 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 388 6.057 6,84 54,83 21.250 332.081
2015-08-04 2015-08-03 4 KMB KIMBERLY CLARK CORP
Common Stock
S - Sale -14.474 105.343 -12,08 115,18 -1.667.163 12.133.754
2015-07-02 2015-06-30 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 366 5.659 6,91 58,13 21.250 328.942
2015-05-15 2015-05-14 4 KMB KIMBERLY CLARK CORP
Stock Option (Right to Buy)
M - Exercise -33.502 0 -100,00
2015-05-15 2015-05-14 4 KMB KIMBERLY CLARK CORP
Common Stock
S - Sale -33.502 119.817 -21,85 111,00 -3.718.722 13.299.687
2015-05-15 2015-05-14 4 KMB KIMBERLY CLARK CORP
Common Stock
M - Exercise 33.502 153.319 27,96 75,22 2.520.030 11.532.701
2015-05-07 2015-05-05 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
A - Award 2.448 19.470 14,38
2015-05-01 2015-04-29 4 KMB KIMBERLY CLARK CORP
Stock Option (Right to Buy)
A - Award 54.191 54.191
2015-04-02 2015-03-31 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 356 5.271 7,25 59,66 21.250 314.493
2015-03-02 2015-02-27 4 KMB KIMBERLY CLARK CORP
Common Stock
F - Taxes -10.071 119.817 -7,75 109,66 -1.104.386 13.139.132
2015-03-02 2015-02-27 4 KMB KIMBERLY CLARK CORP
Common Stock
A - Award 24.006 129.888 22,67
2015-02-17 2015-02-12 4 KMB KIMBERLY CLARK CORP
Stock Option (Right to Buy)
M - Exercise -24.489 0 -100,00
2015-02-17 2015-02-12 4 KMB KIMBERLY CLARK CORP
Common Stock
S - Sale -24.489 105.882 -18,78 109,67 -2.685.750 11.612.259
2015-02-17 2015-02-12 4 KMB KIMBERLY CLARK CORP
Common Stock
M - Exercise 24.489 130.371 23,13 62,07 1.520.047 8.092.206
2015-02-17 2014-12-31 4 KMB KIMBERLY CLARK CORP
Common Stock
G - Gift -5.000 105.882 -4,51
2015-01-05 2014-12-31 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 395 4.915 8,73
2014-10-02 2014-09-30 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 473 4.511 11,71
2014-07-02 2014-06-30 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 506 4.028 14,36 42,02 21.250 169.249
2014-05-08 2014-05-06 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
A - Award 3.016 16.874 21,76
2014-05-05 2014-04-30 4 KMB KIMBERLY CLARK CORP
Stock Option (Right to Buy)
A - Award 48.998 48.998
2014-04-02 2014-03-31 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 493 3.513 16,32
2014-03-04 2014-02-28 4 KMB KIMBERLY CLARK CORP
Common Stock
S - Sale -6.214 0 -100,00 110,35 -685.733
2014-02-19 2014-02-17 4 KMB KIMBERLY CLARK CORP
Common Stock
F - Taxes -9.104 110.882 -7,59 110,24 -1.003.625 12.223.631
2014-02-19 2014-02-17 4 KMB KIMBERLY CLARK CORP
Common Stock
A - Award 23.578 119.986 24,46
2014-02-03 2014-01-30 4 KMB KIMBERLY CLARK CORP
Stock Option (Right to Buy)
M - Exercise -13.751 32.086 -30,00
2014-02-03 2014-01-30 4 KMB KIMBERLY CLARK CORP
Common Stock
S - Sale -13.751 96.408 -12,48 108,00 -1.485.108 10.412.064
2014-02-03 2014-01-30 4 KMB KIMBERLY CLARK CORP
Common Stock
M - Exercise 13.751 110.159 14,26 78,54 1.080.004 8.651.888
2014-01-03 2013-12-31 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 433 3.014 16,78
2013-12-02 2013-11-27 4 KMB KIMBERLY CLARK CORP
Stock Option (Right to Buy)
M - Exercise -17.590 23.454 -42,86
2013-12-02 2013-11-27 4 KMB KIMBERLY CLARK CORP
Common Stock
S - Sale -17.590 96.408 -15,43 108,04 -1.900.366 10.415.602
2013-12-02 2013-11-27 4 KMB KIMBERLY CLARK CORP
Common Stock
M - Exercise 17.590 113.998 18,25 64,81 1.140.008 7.388.210
2013-10-02 2013-09-30 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 521 2.576 25,38
2013-07-02 2013-06-28 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 302 1.025 41,74
2013-05-09 2013-05-07 4/A WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
A - Award 2.003 6.868 41,17
2013-05-08 2013-05-07 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
A - Award 2.100 6.965 43,17
2013-05-03 2013-05-02 4 KMB KIMBERLY CLARK CORP
Stock Option (Right to Buy)
M - Exercise -23.308 0 -100,00
2013-05-03 2013-05-02 4 KMB KIMBERLY CLARK CORP
Common Stock
S - Sale -23.308 96.408 -19,47 104,75 -2.441.513 10.098.738
2013-05-03 2013-05-02 4 KMB KIMBERLY CLARK CORP
Common Stock
M - Exercise 23.308 119.716 24,18 61,02 1.422.254 7.305.070
2013-05-03 2013-05-01 4 KMB KIMBERLY CLARK CORP
Stock Option (Right to Buy)
A - Award 43.567 43.567
2013-04-02 2013-03-29 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 328 721 83,42
2013-02-26 2013-02-22 4 KMB KIMBERLY CLARK CORP
Common Stock
F - Taxes -3.832 96.408 -3,82 94,50 -362.124 9.110.556
2013-02-26 2013-02-22 4 KMB KIMBERLY CLARK CORP
Common Stock
A - Award 9.820 100.240 10,86
2013-01-03 2012-12-31 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 392 392
2012-07-27 2012-07-27 4 KMB KIMBERLY CLARK CORP
Stock Option (Right to Buy)
M - Exercise -34.961 23.308 -60,00
2012-07-27 2012-07-27 4 KMB KIMBERLY CLARK CORP
Stock Option (Right to Buy)
M - Exercise -17.589 41.044 -30,00
2012-07-27 2012-07-27 4 KMB KIMBERLY CLARK CORP
Common Stock
S - Sale -34.961 90.420 -27,88 85,59 -2.992.361 7.739.174
2012-07-27 2012-07-27 4 KMB KIMBERLY CLARK CORP
Common Stock
S - Sale -17.589 125.381 -12,30 85,72 -1.507.729 10.747.659
2012-07-27 2012-07-27 4 KMB KIMBERLY CLARK CORP
Common Stock
M - Exercise 17.589 142.970 14,03 64,81 1.139.943 9.265.886
2012-07-27 2012-07-27 4 KMB KIMBERLY CLARK CORP
Common Stock
M - Exercise 34.961 125.381 38,67 61,02 2.133.320 7.650.748
2012-06-15 2012-06-14 4 KMB KIMBERLY CLARK CORP
Stock Option (Right to Buy)
M - Exercise X -29.679 0 -100,00
2012-06-15 2012-06-14 4 KMB KIMBERLY CLARK CORP
Common Stock
S - Sale X -29.679 90.420 -24,71 82,00 -2.433.678 7.414.440
2012-06-15 2012-06-14 4 KMB KIMBERLY CLARK CORP
Common Stock
M - Exercise X 29.679 120.099 32,82 71,88 2.133.327 8.632.716
2012-05-04 2012-05-02 4 KMB KIMBERLY CLARK CORP
Stock Option (Right to Buy)
A - Award 45.837 45.837
2012-05-03 2012-05-01 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
A - Award 2.459 4.805 104,80
2012-05-02 2012-05-01 4 KMB KIMBERLY CLARK CORP
Stock Option (Right to Buy)
M - Exercise -47.873 0 -100,00
2012-05-02 2012-05-01 4 KMB KIMBERLY CLARK CORP
Stock Option (Right to Buy)
M - Exercise -49.487 0 -100,00
2012-05-02 2012-05-01 4 KMB KIMBERLY CLARK CORP
Common Stock
S - Sale -97.360 90.420 -51,85 78,55 -7.647.375 7.102.256
2012-05-02 2012-05-01 4 KMB KIMBERLY CLARK CORP
Common Stock
M - Exercise 47.873 187.780 34,22 49,61 2.374.980 9.315.766
2012-05-02 2012-05-01 4 KMB KIMBERLY CLARK CORP
Common Stock
M - Exercise 49.487 139.907 54,73 63,99 3.166.673 8.952.649
2012-04-27 2012-04-25 4 KMB KIMBERLY CLARK CORP
Restricted Share Units 04/25/2007
M - Exercise -2.474 0 -100,00
2012-04-27 2012-04-25 4 KMB KIMBERLY CLARK CORP
Common Stock
G - Gift -1.000 90.420 -1,09
2012-04-27 2012-04-25 4 KMB KIMBERLY CLARK CORP
Common Stock
F - Taxes -902 91.420 -0,98 78,73 -71.014 7.197.496
2012-04-27 2012-04-25 4 KMB KIMBERLY CLARK CORP
Common Stock
M - Exercise 2.474 92.322 2,75
2012-02-29 2012-02-26 4 KMB KIMBERLY CLARK CORP
Common Stock
F - Taxes -11.692 89.848 -11,51 71,81 -839.603 6.451.985
2012-02-29 2012-02-26 4 KMB KIMBERLY CLARK CORP
Common Stock
A - Award 32.075 101.540 46,17
2012-02-01 2012-01-30 4 KMB KIMBERLY CLARK CORP
Stock Option (Right to Buy)
M - Exercise -36.803 0 -100,00
2012-02-01 2012-01-30 4 KMB KIMBERLY CLARK CORP
Stock Option (Right to Buy)
M - Exercise -24.558 0 -100,00
2012-02-01 2012-01-30 4 KMB KIMBERLY CLARK CORP
Stock Option (Right to Buy)
M - Exercise -38.595 0 -100,00
2012-02-01 2012-01-30 4 KMB KIMBERLY CLARK CORP
Common Stock
S - Sale -99.956 69.465 -59,00 71,31 -7.127.652 4.953.403
2012-02-01 2012-01-30 4 KMB KIMBERLY CLARK CORP
Common Stock
M - Exercise 24.558 169.421 16,95 63,14 1.550.624 10.697.462
2012-02-01 2012-01-30 4 KMB KIMBERLY CLARK CORP
Common Stock
M - Exercise 36.803 144.863 34,06 61,59 2.266.697 8.922.112
2012-02-01 2012-01-30 4 KMB KIMBERLY CLARK CORP
Common Stock
M - Exercise 38.595 108.060 55,56 58,73 2.266.684 6.346.364
2008-04-24 2008-04-23 4 KMB KIMBERLY CLARK CORP
Stock Option (Right to Buy)
A - Award 49.487 49.487
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)